ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

ORGS Orgenesis Inc

0,527
-0,016 (-2,95%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Orgenesis Inc ORGS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,016 -2,95% 0,527 22:30:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,547 0,505 0,5796 0,527 0,543
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
15.4.202423:07GLOBEOrgenesis Provides Year End Business Update
10.4.202418:00GLOBEGermfree and Orgenesis Announce Asset Purchase and Strategic..
18.3.202413:30GLOBEVered Caplan, CEO of Orgenesis, to Present at the..
13.3.202413:30GLOBEOrgenesis Consortium Awarded €1.5M EUR Grant from the..
04.3.202414:30GLOBEOrgenesis Inc. Announces $2.3 Million Private Placement
29.2.202414:30GLOBEOrgenesis Consortium Awarded €2.0M EUR Grant from Walloon..
31.1.202415:20EDGAR2Form 8-K - Current report
31.1.202415:15GLOBEOrgenesis Acquires Control of Octomera with the Goal of..
24.1.202422:05EDGAR2Form 8-K - Current report
22.1.202422:01EDGAR2Form 8-K - Current report
08.1.202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202423:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.1.202412:02EDGAR2Form 8-K - Current report
14.11.202314:30GLOBEOrgenesis Ranked No. 171st Fastest-Growing Company in North..
13.11.202322:15GLOBEOrgenesis Provides Business Update for the Third Quarter of..
09.11.202313:41EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08.11.202315:24EDGAR2Form 8-K - Current report
08.11.202315:00GLOBEOrgenesis Inc. Announces Pricing of $1.1 Million Registered..
02.11.202313:00GLOBEOrgenesis Announces Expanded Partnership Between Octomera..
31.10.202302:30GLOBEOrgenesis Announces Withdrawal of Proposed Public Offering
30.10.202321:07GLOBEOrgenesis Announces Proposed Underwritten Public Offering
21.9.202314:00GLOBECGT Global and Octomera Enter Agreement to Expand Cell &..
06.9.202313:00GLOBECell and Gene Therapy Industry Pioneer & GMP Expert, Gerhard..
05.9.202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202313:00GLOBEOrgenesis Provides Business Update for Second Quarter of..
10.8.202323:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202314:30GLOBEOrgenesis Schedules Second Quarter 2023 Business Update..
13.7.202314:30GLOBEOrgenesis Appoints Finance Veteran Elliot Maltz as its Chief..
12.7.202322:05EDGAR2Form 8-K - Current report
11.7.202313:00GLOBEOrgenesis Announces Name Change of Morgenesis Business Unit..
07.6.202313:00GLOBEOrgenesis and University of California, Davis Sign..
30.5.202315:30GLOBEClaudia Zylberberg Appointed as Independent Board Member of..
22.5.202313:30GLOBEOrgenesis Academy Graduates First Class of Cell and Gene..
19.5.202314:30GLOBEOrgenesis to Participate in Benchmark’s 3rd Annual..
18.5.202313:30GLOBEOrgenesis Announces Collaboration Agreement with SCTbio to..
10.5.202322:30GLOBEOrgenesis Provides Business Update for the First Quarter of..
10.5.202316:00GLOBEOrgenesis Secures an Additional $5 Million Investment from..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock